Drug intelligence / Profile preview

TearsAgain

Development stage
Unknown
Lead developer
Circius Pharma
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

TearsAgain is a family of over-the-counter (OTC) eye care products, including eye sprays and drops, marketed by the Swedish company Circius Pharma. It is primarily indicated for the relief of dry eye symptoms and blepharitis. The eye spray formulation is particularly notable for its use of liposomes (phospholipids) that integrate into and stabilize the lipid layer of the tear film. This action helps to reinforce the eye's natural protective barrier, significantly reducing the evaporation of the aqueous layer of the tears, which is a leading cause of evaporative dry eye. The product is designed for easy application to closed eyelids, from where the liposomes migrate to the tear film to provide long-lasting moisturization and relief.

Brand names
TearsAgain
Other names
TearsAgain Eye SprayTearsAgain Eye Drops
02

Targets

P2RY2 (P2Y Purinoceptor 2)

Beyond the preview

Go deeper on TearsAgain.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TearsAgain.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call